Persea Americana for Total Health (PATH)-2
PATH-2
1 other identifier
interventional
45
1 country
1
Brief Summary
The goal of this clinical trial is to learn about the effects of avocado consumption on gastrointestinal health in adults with overweight and obesity. The main questions is aims to answer are: How does avocado consumption affect the gut microbiome? How does avocado consumption affect thinking? Are there connections between the microbiome and cognition? Participants will be asked to eat provided meals with and without avocados for three 4-week periods. At the end of each 4-week period, participants will be asked to provide stool samples and complete computer games that assess thinking and memory.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2023
CompletedStudy Start
First participant enrolled
July 11, 2023
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedOctober 13, 2023
October 1, 2023
12 months
June 27, 2023
October 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Fecal microbial species
Feacalibacterium spp., bacteria capable of producing SCFA and secondary bile acid synthesis measured using metagenomic sequencing
4 weeks
Fecal microbial genes
Microbial genes involved in short-chain fatty acids and secondary bile acid synthesis measured using metagenomic sequencing
4 weeks
Concentration of fecal bile acids
Fecal bile acid concentrations using HPLC in avocado and active comparator vs. control,
4 weeks
Concentration of fecal SCFA
Fecal SCFA concentrations using GC-MS in avocado and active comparator vs. control,
4 weeks
Secondary Outcomes (3)
Cognitive function
4 weeks
Subjective gastrointestinal tolerance via questionnaire
4 week
Digestive health using stool records/Bristol Stool Scale
4 week
Other Outcomes (5)
Fecal microbiome
4 weeks
Inflammation
4 weeks
Intestinal permeability
up to 4 weeks
- +2 more other outcomes
Study Arms (3)
Avocado
EXPERIMENTALThe experimental treatment will contain an avocado. Avocados will be consumed daily for 4 weeks.
Fiber + Oil
ACTIVE COMPARATORThe active comparator will have a snack that mimics the fiber and fatty acid composition found in avocados and will be consumed daily for 4 weeks.
Standard American Diet
SHAM COMPARATORThe sham comparator contains foods and beverages of a standard American diet and will be consumed daily for 4 weeks.
Interventions
The active comparator will contain a snack with oils and fibers that mimic an avocado
The sham comparator will contain foods/beverages that mimic a standard American Diet
Eligibility Criteria
You may qualify if:
- Participants must be between the ages of 25 and 74 years old
- BMI ≥ 25 kg/m2
- Ability to drop off fecal sample within 15 minutes of defecation
- /20 or corrected vision
You may not qualify if:
- Avocado allergy or intolerance
- Food allergies or intolerances
- Prior diagnosis of liver or gastrointestinal disease (primary biliary cirrhosis or gallbladder disease, chronic constipation, diarrhea, Crohn's disease, celiac disease, ulcerative colitis, irritable bowel syndrome, diverticulosis, stomach or duodenal ulcers), diabetes, hepatitis, HIV, or cancer
- Women that are pregnant, have given birth in the previous 12 months or are lactating
- Individuals that smoke, use tobacco, abuse drugs, or consume \> 2 alcoholic beverages per day.
- \> 5% weight change in the past month or \> 10% change in the past six months
- Oral antibiotics during the previous 6 weeks.
- Currently taking lipid-lowering medications, oral hypoglycemic agents, or insulin.
- History of malabsorptive or restrictive bariatric surgeries (e.g., gastric bypass, sleeve gastrectomy, adjustable gastric band) or gall bladder removal surgery.
- Are unable to consume the experimental meals/snacks.
- Allergic to latex
- Concurrent enrollment in another dietary, exercise, or medication study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois, Urbana Champaign
Urbana, Illinois, 61801, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hannah Holscher, PhD, RD
University of Illinois Urbana Champaign
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 27, 2023
First Posted
July 12, 2023
Study Start
July 11, 2023
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
October 13, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share